— Know what they know.
Not Investment Advice
Also trades as: VRAY (NASDAQ) · $vol 2M · 6L9.F (FSX) · $vol 0M

VRAYQ OTC

ViewRay, Inc.
1W: +0.0% 1M: -99.0% 3M: -99.0% YTD: -90.0% 1Y: -90.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 46 · $18340 mcap · 175M float · 0.0036% daily turnover · Short 49% of daily vol

Income Trends

Revenue
$102M +45.8% ▲
5Y CAGR: +24.6%
Gross Profit
$10M +2898.5% ▲
5Y CAGR: +9.7%
Operating Income
-$107M -3.4% ▼
Net Income
-$107M +2.5% ▲
EPS (Diluted)
$-0.59 +11.9% ▲
EBITDA
-$97M +2.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$81M$88M$57M$70M$102M
YoY Growth+137.8%+8.4%-35.0%+23.0%+45.8%
Cost of Revenue$74M$93M$61M$70M$92M
Gross Profit$7M-$5M-$4M$335K$10M
Gross Margin8.2%-6.2%-7.1%0.5%9.8%
R&D Expenses$17M$19M$25M$32M$32M
SG&A Expenses$65M$92M$77M$72M$83M
Operating Expenses$82M$115M$102M$104M$117M
Operating Income-$75M-$121M-$106M-$104M-$107M
Operating Margin-92.7%-137.6%-185.9%-147.8%-104.8%
Interest Expense$8M$4M$3M$4M$5M
Income Before Tax-$76M-$120M-$108M-$110M-$107M
Tax Expense$0$0$0$0$0
Net Income-$76M-$120M-$108M-$110M-$107M
Net Margin-94.4%-136.9%-189.3%-156.9%-105.0%
EPS (Diluted)$-0.98$-1.18$-0.73$-0.67$-0.59
EBITDA-$65M-$111M-$98M-$100M-$97M
Shares Outstanding81M102M148M165M181M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms